Clinical Trial Update: Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating adjuvant high-dose, sequential chemotherapy in patients with resected breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Yale University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED